Patient no. | Age (y) | Gleason score | PSA at examination (ng/mL) | Local tumor growth (n) | Lymph node metastases (n) | Bone metastases (n) |
1 | 54 | 9 (4 + 5) | 124.0 | 1 | >10 | >10 |
2 | 55 | 8 (4 + 4) | 112.0 | 1 | 0 | 0 |
3 | 60 | 6 (3 + 3) | 13.4 | 1 | 0 | 0 |
4 | 66 | 8 (4 + 4) | 75.0 | 1 | >10 | 4 |
5 | 80 | 8 (4 + 4) | 95.4 | 1 | 0 | 0 |
6 | 82 | 9 (5 + 4) | 240.0 | 1 | >10 | >10 |
7 | 66 | 7b (4 + 3) | 87.0 | 3 | 0 | 0 |
8 | 66 | 7a (3 + 4) | 61.6 | 1 | 0 | 0 |
9 | 69 | 7a (3 + 4) | 10.0 | 2 | 0 | 0 |
10 | 62 | 7b (4 + 3) | 83.0 | 1 | 1 | 0 |
11 | 79 | 8 (4 + 4) | 279.8 | 1 | >10 | 0 |
12 | 65 | 7a (3 + 4) | 55.2 | 1 | 0 | 0 |